NEUROONE MEDICAL TECHNOLOGIES Corp: Reports fiscal 2026 revenue of $10,500,000

What happened

• On Oct 5, 2026, NEUROONE MEDICAL TECHNOLOGIES Corp issued a press release reporting preliminary, unaudited financial results for the fiscal quarter and year ended Sep 30, 2026.
• The company reported annual total revenue of approximately $10,500,000 for the year ended Sep 30, 2026 and quarterly revenue of approximately $3,800,000 for the quarter ended Sep 30, 2026.
• The company also reported receipt during Sep 2026 of a purchase order for $4,500,000; approximately $1,000,000 of that order shipped by Sep 30, 2026, with the remaining $3,600,000 expected to ship in fiscal 2027 subject to manufacturing and delivery schedules.

Key details

• Annual revenue: $10,500,000 for the year ended Sep 30, 2026.
• Quarterly revenue: $3,800,000 for the quarter ended Sep 30, 2026.
• Purchase order: $4,500,000 received in Sep 2026; $1,000,000 shipped by Sep 30, 2026; $3,600,000 expected to ship in fiscal 2027 (Q1 into Q2), subject to manufacturing and delivery schedules.
• The press release is furnished as Exhibit 99.1 to the Form 8-K; the reported results are preliminary, unaudited and subject to completion of management’s review and other closing procedures.

Why it may matter

• The filing reports Item 2.02 (results of operations and financial condition) and Item 8.01 (other events), covering the company’s preliminary, unaudited fiscal 2026 revenue figures and the reported purchase order.
• A filing does not show why the insider traded or why the company acted.